Increased circulating myostatin in patients with type 2 diabetes mellitus

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 32, Issue 4, 2012, Pages 534-539

  Wang, Fang ^a   Liao, Yonggan ^b   Li, Xuefeng ^b   Ren, Chunlin ^b   Cheng, Changming ^b   Ren, Yongsheng ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Body mass index; Insulin resistance index; Myostatin; Type 2 diabetes

Indexed keywords

INSULIN; LIPID; MSTN PROTEIN, HUMAN; MYOSTATIN;

ARTICLE; BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; MYOSTATIN;

EID: 84865634036     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-012-0092-9     Document Type: Article

References (37)

1. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health, 2005,4(1):2
2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 2005,365(9467):1333-1346
3. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 1997,387(6628):83-90
4. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA, 2001,98(16): 9306-9311
5. Philip B, Lu Z, Gao Y. Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal, 2005,17(3):365-375
6. Yang W, Zhang Y, Li Y, et al. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem, 2007,282(6):3799-3808
7. Huang Z, Chen D, Zhang K, et al. Regulation of myostatin signalling by c-Jun N-terminal kinase in C2C12 cells. Cell Signal, 2007,19(11):2286-2295
8. Zhu X, Topouzis S, Liang LF, et al. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine, 2004,26(6):262-272
9. Kim HS, Liang L, Dean RG, et al. Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures. Biochem Biophys Res Commun, 2001,281(4): 902-906
10. Chen Y, Ye J, Cao L, et al. Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Int J Biochem Cell Biol, 2010,42(12):2072-2081
11. Mitchell MD, Osepchook CC, Leung KC, et al. Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab, 2006,91(4):1434-1437
12. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest, 2002,109(5):595-601
13. Lin J, Arnold HB, Della-Fera MA, et al. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun, 2002,291 (3):701-706
14. Williams MS. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med, 2004,351 (10):1030-1031
15. Hocquette JF, Bas P, Bauchart D, et al. Fat partitioning and biochemical characteristics of fatty tissues in relation to plasma metabolites and hormones in normal and double-muscled young growing bulls. Comp Biochem Physiol A Mol Integr Physiol, 1999,122(1):127-138
16. Zhao B, Wall RJ, Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun, 2005,337 (1):248-255
17. Mukherjee A, Sidis Y, Mahan A, et al. FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci USA, 2007,104 (4):1348-1353
18. Allen DL, Cleary AS, Speaker KJ, et al. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab, 2008,294(5): E918-927
19. Milan G, Dalla Nora E, Pilon C, et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab, 2004,89(6):2724-2727
20. Hittel DS, Berggren JR, Shearer J, et al. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes, 2009,58(1):30-38
21. Zachwieja JJ, Smith SR, Sinha-Hikim I, et al. Plasma myostatin- immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration. J Gravit Physiol, 1999,6(2):11-15
22. Reardon KA, Davis J, Kapsa RM, et al. Myostatin, insulin like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve, 2001,24(7):893-899
23. Hayot M, Rodriguez J, Vernus B, et al. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol Cell Endocrinol, 2011,332(1-2):38-47
24. Yarasheski KE, Bhasin S, Sinha-Hikim I, et al. Serum myostatin immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging, 2002,6(5):343-348
25. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985,28(7):412-419
26. Lenk K, Schur R, Linke A, et al. Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. Eur J Heart Fail, 2009,11(4):342-348
27. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA, 1998,95(25):14938-14943
28. Mendler L, Baka Z, Kovács-Simon A, et al. Androgens negatively regulate myostatin expression in an androgen-dependent skeletal muscle. Biochem Biophys Res Commun, 2007,361(1):237-242
29. Hill JJ, Qiu Y, Hewick RM, et al. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol, 2003,17(6):1144-1154
30. Lee SJ. Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One, 2008,3(2): e1628
31. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr, 2006,83(4):735-743
32. Chen Y, Cao L, Ye J, et al. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin. Biochem Biophys Res Commun, 2009,388(1):112-116
33. Charlton M, Nair KS. Protein metabolism in insulin-dependent diabetes mellitus. J Nutr, 1998,128(2): 323S-327S
34. Welle S, Burgess K, Mehta S. Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice, Am J Physiol Endocrinol Metab, 2009,296(3):E567-E572
35. Allen DL, Unterman TG. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol, 2007,292(1):C188-C199
36. Liu CM, Yang Z, Liu CW, et al. Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice. Cancer Gene Ther, 2007,14 (12):945-952
37. Wagner KR, Fleckenstein JL, Amato AA, et al. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol, 2008,63(5):561-571